Navigated laser therapy for diabetic macular oedema

Marcus Kernt, Michael Ulbig, Anselm Kampik, Aljoscha S. Neubauer

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Navigated laser therapy introduces computerised assistance systems to retinal laser photocoagulation treatment. Some of the main benefits the Navilas system offers over conventional laser include high precision and safety and provides additional advantages in terms of standardisation of planning, execution, documentation, quality assurance and better overall treatment comfort for the patient. Navigated laser therapy is being used with good success in the treatment of diabetic macular oedema (DMO), retinal vein occlusions (RVO) and fastpattern navigated panretinal photocoagulation in proliferative diabetic retinopathy (PDR). In centre-involving DMO, a combination of antivascular endothelial growth factor (VEGF) and macular laser may provide advantages over anti-VEGF monotherapy. In terms of navigated laser therapy, recent study data from our clinic and other institutions indicate that combined initial anti-VEGF and navigated macular laser therapy allows treatment success to be achieved and maintained with a significantly reduced number of interventions.

Original languageEnglish
Pages (from-to)66-69
Number of pages4
JournalEuropean Endocrinology
Volume10
Issue number1
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Diabetes
  • Diabetic retinopathy
  • ETDRS
  • Macular oedema
  • Navigated laser therapy
  • Pattern laser

Fingerprint

Dive into the research topics of 'Navigated laser therapy for diabetic macular oedema'. Together they form a unique fingerprint.

Cite this